Oxford Cannabinoid signs drug development deal with Stemtech
LONDON, UK: Oxford Cannabinoid Technologies (OCT) has signed a new drug development agreement with Stemtech. Stemtech is a contract research organisation based in Oxford and led by Dr Zameel Cader, which generates re-programmed human stem cells for research and drug…